http://fareastgizmos.com/wp-content/uploads/2013/05/nano_technology_MIT.jpg

Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed


Daniel_G_anderson_MITInjectable nanoparticles developed at MIT may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin. The nanoparticles were designed to sense glucose levels in the body and respond by secreting the appropriate amount of insulin, thereby replacing the function of pancreatic islet cells, which are destroyed in patients with Type 1 diabetes. Ultimately, this type of system could ensure that blood-sugar levels remain balanced and improve patients’ quality of life, according to the researchers.

“Insulin really works, but the problem is people don’t always get the right amount of it. With this system of extended release, the amount of drug secreted is proportional to the needs of the body,” says Daniel Anderson, an associate professor of chemical engineering and member of MIT’s Koch Institute.
Continue reading:

READ  MIT researchers develop glass that’s anti-fogging, self-cleaning and free of glare



There are no comments

Add yours